Home/Filings/4/0001062993-23-003827
4//SEC Filing

CHANG JOSEPH Y 4

Accession 0001062993-23-003827

CIK 0001021561other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 6:14 PM ET

Size

8.3 KB

Accession

0001062993-23-003827

Insider Transaction Report

Form 4
Period: 2023-02-14
CHANG JOSEPH Y
Chief Scientific Officer
Transactions
  • Tax Payment

    Class A Common Stock

    2023-02-15$45.38/sh1,981$89,89821,234 total
  • Award

    Employee Stock Option (Right to Buy)

    2023-02-14+17,69283,810 total
    Exercise: $30.45From: 2023-02-14Exp: 2027-02-15Class A Common Stock (17,692 underlying)
Holdings
  • Class A Common Stock

    (indirect: By Trust)
    78,068
Footnotes (3)
  • [F1]Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units.
  • [F2]This report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F3]On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 14, 2023, the performance criteria were met, resulting in the vesting of the amount shown above.

Issuer

NU SKIN ENTERPRISES, INC.

CIK 0001021561

Entity typeother

Related Parties

1
  • filerCIK 0001184201

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 6:14 PM ET
Size
8.3 KB